Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.
about
Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus.Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus.Antiphospholipid antibodies: paradigm in transition.Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.Risk factors for thrombosis in lupus patientsFluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study.Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome.Anticardiolipin versus lupus anticoagulant tests: no final judgment.Prevalence of antiphospholipid antibodies in patients with fetal lossProspective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus.Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?Long-term follow-up of ischaemic retinopathy in the antiphospholipid syndrome with lupus-like disease.Thrombosis in systemic lupus erythematosus: a French collaborative studyAnnexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome.Antiphospholipid syndrome: multiple mechanisms.Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant.Lupus in Baltimore: evidence-based 'clinical pearls' from the Hopkins Lupus Cohort.Antiphospholipid antibodies and Mycoplasma pneumoniae infection.Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE.Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosusComplexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces.
P2860
Q33363443-F3178E61-6F7F-4A99-8B7C-FDE390E56574Q33382515-9BCDE19B-7EEF-4DCF-B5E2-559AD5BA0CC4Q33382848-7B2912C3-DBFB-4082-9ED7-4D9DD0F9CFDDQ33392824-EB06FF8E-C8DB-4BEC-ABBA-5FF3EEBFFF74Q33417102-8DB7F458-F468-4324-AC9E-18E75D5E460CQ33424619-63BCED7E-4BDC-4E8C-AA96-A3A4E7C590B2Q33547975-DF8ED665-BD92-42D7-87CF-60E7E17036B0Q33561408-E92C6E9B-9F1D-498D-819D-F5D2A7995DA2Q33563796-F4DCC3C1-3E3E-43BB-8CA9-63123C49FF11Q33564380-7BB014B9-0FD1-4CC6-8D36-C9C153F41456Q33566129-7A5E7098-462E-40D3-B754-E1E92487896DQ34057664-BD9021AD-C93D-4E73-B506-6F6E4D61484BQ35626838-771221B2-FF4B-4CBA-8E41-C39F8B5F2AB4Q35638142-19841D1C-0E93-4CDE-9B53-0D62052999A5Q35775322-345FDC55-3970-4755-B17B-8BDF683B5FABQ36303250-61089886-7BF1-43D4-8F31-BD17D86B036AQ36373318-C5925378-B0AE-4D9D-BD6A-A4A110FB61CEQ36718107-490AE0E8-EE3E-4225-AC35-57F1E80C0C40Q37063656-EC588B05-1650-4468-AD9D-B82EFDC27CB1Q37111561-3DA0981E-0C1D-4674-A253-A05AADDC8F44Q43622736-C3AC3C70-B893-44C8-87A7-68050F1AC801
P2860
Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.
description
1988 nî lūn-bûn
@nan
1988 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Coagulation screen is more spe ...... otic subset of lupus patients.
@ast
Coagulation screen is more spe ...... otic subset of lupus patients.
@en
type
label
Coagulation screen is more spe ...... otic subset of lupus patients.
@ast
Coagulation screen is more spe ...... otic subset of lupus patients.
@en
prefLabel
Coagulation screen is more spe ...... otic subset of lupus patients.
@ast
Coagulation screen is more spe ...... otic subset of lupus patients.
@en
P2093
P2860
P356
P1476
Coagulation screen is more spe ...... otic subset of lupus patients.
@en
P2093
Blokzijl L
De Groot PG
Gmelig Meyling FH
Hasselaar P
P2860
P304
P356
10.1136/ARD.47.5.364
P407
P577
1988-05-01T00:00:00Z